Research projects:

  • Human induced pluripotent stem cell (hiPSC) technologies in psychiatric molecular genetics (Figure 1)
  • Neuro-immune interactions (Figure 2)
  • Identifying the polygenic basis of the human brain and neurodevelopmental disorders 
  • Understanding the function of ANK3 in psychotic disorders
  • Identifying mechanisms of rare genetic variants in population level brain imaging genetics for clinical subtyping in neurodevelopmental disorders
  • Prediction of longitudinal outcome and brain phenotype by polygenic risk scores
  • Genetics of neuropsychopharmaceutics
  • Cooperation and biobanking with large-scale studies including the national cohorts and further collaboration with other large-scale studies for validation and QC steps

 

Figure 1 A) Representative image of control human induced pluripotent stem cell (iPSC)-derived brain cortical spheroids (hCS) at day 150 of differentiation. B) MAP2/VGLUT1/DAPI immunohistochemistry staining of human iPSC-derived mature cortical spheroid. C) UMAP clustering of single cell RNA sequencing of a healthy donor iPSC-derived cortical spheroid. Provided by Jordi R. Osete

 

Figure 2. Characterization of iPSC-derived astrocytes from CTRL and SCZ donors . Cells from day 40 cultures stained positive for the key astrocyte markers GFAP, S100B, and AQP4. Scale bar: 200 μm. Provided by Attila Szabo

 

 
Page visits: 2752